nirogacestat
springworks therapeutics
['defi ', 'nirogacestat', 'gamma', 'heidelberg', 'springworks']
 on saturday at #esmo2022, principal investigator bernd kasper, md, ( ) presented the data from phase 3 #defi clinical trial for #nirogacestat (a gamma secretase inhibitor) in #desmoid tumor patients. press release: 
The Desmoid Tumor Research Foundation (DTRF) is the only 501(c)3 in the U.S. solely dedicated to finding a cure for desmoid tumors, a rare soft tissue sarcoma.